BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 9229367)

  • 41. High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis.
    Ishikura K; Wada H; Kamikura Y; Hattori K; Fukuzawa T; Yamada N; Nakamura M; Nobori T; Nakano T
    Am J Hematol; 2004 Aug; 76(4):338-42. PubMed ID: 15282665
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiphospholipid antibodies, haemostatic variables and thrombosis--a survey of 144 patients.
    Ames PR; Pyke S; Iannaccone L; Brancaccio V
    Thromb Haemost; 1995 May; 73(5):768-73. PubMed ID: 7482401
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence and clinical significance of antiphospholipid antibodies to noncardiolipin antigens in systemic lupus erythematosus.
    Toschi V; Motta A; Castelli C; Gibelli S; Cimminiello C; Molaro GL; Gibelli A
    Haemostasis; 1993; 23(5):275-83. PubMed ID: 8175049
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Antiphospholipid syndrome and stroke].
    Kitagawa Y
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Homocysteine, antiphospholipid antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
    Martínez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Rueda M; Aguirre C
    Lupus; 2004; 13(12):927-33. PubMed ID: 15645748
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibody profiles for the diagnosis of antiphospholipid syndrome.
    Pengo V; Biasiolo A; Pegoraro C; Cucchini U; Noventa F; Iliceto S
    Thromb Haemost; 2005 Jun; 93(6):1147-52. PubMed ID: 15968401
    [TBL] [Abstract][Full Text] [Related]  

  • 47. BF*F allotype of the alternative pathway of complement: A marker of protection against the development of antiphospholipid antibodies in patients with systemic lupus erythematosus.
    Picceli VF; Skare TL; Nisihara RM; Nass FR; Messias-Reason IT; Utiyama SR
    Lupus; 2016 Apr; 25(4):412-7. PubMed ID: 26537423
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiphospholipid antibodies--our experience.
    Srikrishna A; Sitalakshmi S; Devi S; Damodar P; Varghese J; Suresh J; Mathew T
    Indian J Pathol Microbiol; 2004 Apr; 47(2):174-7. PubMed ID: 16295461
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antiphospholipid Antibodies and Autoimmune Haemolytic Anaemia: A Systematic Review and Meta-Analysis.
    Ames PRJ; Merashli M; Bucci T; Pastori D; Pignatelli P; Arcaro A; Gentile F
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32527000
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study.
    Stojanovich L; Kontic M; Djokovic A; Marisavljevic D; Ilijevski N; Stanisavljevic N; Mikovic Z; Petkovic M; Kovcin V
    Clin Exp Rheumatol; 2013; 31(2):234-42. PubMed ID: 23306109
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antiphospholipid antibodies and the risk of adverse pregnancy outcomes in patients with systemic lupus erythematosus: a systematic review and meta-analysis.
    Huang J; Zhu Q; Wang B; Wang H; Xie Z; Zhu X; Zhao T; Yang Z
    Expert Rev Clin Immunol; 2024 Jul; 20(7):793-801. PubMed ID: 38445835
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Childhood-onset systemic lupus erythematosus: antiphospholipid antibodies in 37 patients and their first-degree relatives.
    Molta C; Meyer O; Dosquet C; Montes de Oca M; Babron MC; Danon F; Kaplan C; Clémenceau S; Castellano F; Levy M
    Pediatrics; 1993 Dec; 92(6):849-53. PubMed ID: 8233748
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
    Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N
    Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies.
    Zuily S; Regnault V; Selton-Suty C; Eschwège V; Bruntz JF; Bode-Dotto E; De Maistre E; Dotto P; Perret-Guillaume C; Lecompte T; Wahl D
    Circulation; 2011 Jul; 124(2):215-24. PubMed ID: 21690492
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Catastrophic antiphospholipid syndromes in systemic lupus erythematosus.
    Stratta P; Canavese C; Ferrero S; Grill A; Salomone M; Schinco PC; Fusaro E; Montaruli B; Santi S; Piccoli G
    Ren Fail; 1999 Jan; 21(1):49-61. PubMed ID: 10048117
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome.
    Avcin T; Silverman ED
    Lupus; 2007; 16(8):627-33. PubMed ID: 17711899
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elevated partial antiphospholipid score is a strong risk factor for thrombosis in patients with systemic lupus erythematosus: a validation study.
    Chen J; Sun S; Yan Q; Bao C; Fu Q
    Clin Rheumatol; 2016 Feb; 35(2):333-40. PubMed ID: 26753544
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Leiden, G20210A mutations in prothrombin gene and antiphospholipid antibodies in systemic lupus erythematosus and antiphospholipid syndrome].
    Reshetniak TM; Patrushev LI; Stukacheva EA; Miroshnikov AI; Tikhonova TL; Nasonov EL; Alekberova ZS
    Ter Arkh; 2000; 72(5):34-8. PubMed ID: 11109617
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature.
    Galli M; Luciani D; Bertolini G; Barbui T
    Blood; 2003 Mar; 101(5):1827-32. PubMed ID: 12393574
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome.
    Parkpian V; Verasertniyom O; Vanichapuntu M; Totemchokchyakarn K; Nantiruj K; Pisitkul P; Angchaisuksiri P; Archararit N; Rachakom B; Ayurachai K; Janwityanujit S
    Clin Rheumatol; 2007 Oct; 26(10):1663-70. PubMed ID: 17332980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.